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Abstract
Background: The objectives of the survey were to identify the level of influenza vaccination
coverage in five European countries between 2001 and 2007, to understand the drivers and
barriers to vaccination, to assess vaccination intentions for the winter 2007/08 as well as major
encouraging factors for vaccination.
Methods:  Between 2001 and 2007, representative household surveys were performed with
telephone or mailed (France) interviews of individuals aged 14 and above. The questionnaire used
in the UK, Germany, Italy, France and Spain was essentially the same in all seasons. The data were
subsequently pooled. Four target groups were defined for the analysis: 1) persons aged 65 years
and over; 2) persons working in the medical field; 3) chronically ill persons and 4) combined target
group composed of individuals belonging to one or more of the previous groups 1, 2 or 3.
Results: In 2006/07, vaccination coverage was, 25.0% in UK, 27.4% in Germany, 21.8% in Spain,
24.2% in France and 24.4% in Italy. During six influenza seasons (2001–2007), vaccination coverage
showed a slight positive trend in the five countries (p ≤ 0.0001). In the elderly (≥ 65 years), across
all countries, no significant trend was seen; the vaccination rate decreased non-significantly from a
peak of 64.2% in season 2005/06 to 61.1% in season 2006/07. The most frequent reason for getting
vaccinated was a recommendation by the family doctor or nurse (51%), and this was also perceived
as the major encouraging factor for vaccination (61%). The main reason for not getting vaccinated
was feeling unlikely to catch the flu (36%).
Conclusion: In the UK, Germany and Spain, influenza vaccination coverage rates in season 2006/
07 dropped slightly compared to the previous season. However, a trend of increasing vaccination
coverage was observed from 2001/02 to 2006/07 across Europe. The family doctor is the major
source of encouragement for individuals getting vaccinated. Efforts to overcome the barriers to
vaccination need to be put in place to reach the WHO objective of 75% coverage in the elderly by
2010. This is a major challenge to be faced by governments, healthcare workers and healthcare
organisations.
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Background
Seasonal influenza is one of the principal causes of vac-
cine-preventable disease with up to 500,000 deaths per
year worldwide [1]. It can cause mild to severe illness,
whereas the very young, the elderly and those with certain
chronic health conditions are at risk for serious influenza
complication [2,3]. Influenza is a contagious respiratory
illness caused by influenza viruses. Point mutations occur
during viral replication and lead to frequent antigenic
changes. Antigenic drift results in new influenza virus var-
iants which can cause seasonal Influenza epidemics and
require the modification of the vaccine each year [4].
However, the primary strategy for preventing the flu is get-
ting vaccinated against influenza annually. The surveil-
lance network for humans and targeted influenza
vaccination programmes including specific contingency
plans, adequate stockpiling of antivirals, investing in pan-
demic vaccine research and promoting domestic produc-
tion of influenza vaccines are cornerstones in national
and international pandemic preparedness plans [5].
Several studies evaluated the economic impact of vaccina-
tion, particularly among children, healthy working adults
and the elderly. Cost savings were most evident in chil-
dren under high risk conditions by diminishing indirect
costs caused by parental working days lost due to the care
of their sick children [6]. The vaccination of healthy adults
has shown to be cost-effective and cost saving by reducing
the indirect costs which are associated with work absen-
teeism or affected work productivity [7]. The elderly are
the group at highest risk for influenza complications.
Hence, vaccination of this part of the population provides
considerable economic benefits [8].
In the five European countries covered by this survey, offi-
cial vaccination recommendations are very alike. They
cover: 1) people aged 65 years and over (as an exception,
Germany uses a cut-off of 60 years), 2) individuals of age
6 months or above with high risk chronic conditions
including cardio-pulmonary diseases, diabetes mellitus
and immunologic disorders, or HIV/AIDS (except in Italy
where the latter group is not included), 3) nursing home
residents, 4) health and social care workers [9,10]. Some
countries make additional recommendations which were
not explicitly covered by this survey [11,12]. The age-
based recommendations for 60+ and 65+ respectively
have been implemented before 2001/02 and were not
changed during the whole study period.
Despite public awareness and efforts by policy makers,
physicians and health care providers, influenza vaccina-
tion rates and vaccine manufacturing capacities need to be
increased substantially to achieve the degree of baseline
preparedness required in case of a surge in immunization
uptake when a influenza pandemic occurs.
There is evidence in earlier publications investigating vac-
cination coverage rates in Europe that the threat of avian
influenza impacted on vaccination rates in several Euro-
pean countries [13-15]. This survey, based on cross-sec-
tional data, was conducted in order to examine changes in
influenza vaccination coverage during six consecutive sea-
sons and to monitor behaviours, with a particular focus
on high risk target groups. Furthermore, related motiva-
tions and barriers, and vaccination intentions for the com-
ing season 2007/08 were addressed.
Methods
This survey is an ongoing international assessment of
influenza immunization uptake in Germany, UK, Italy,
France and Spain. New countries added in 2006/07 were
Austria, Czech Republic, Finland, Ireland, Poland and
Portugal. However, this report only covers the original five
countries. During six influenza seasons, from 2001/02 to
2006/07, population-based surveys were carried out in
December and January among households representative
of the non- institutionalized population. The same meth-
odology was used from the beginning. Except in France,
interviews were realized via computer-assisted telephone
interviews (CATIs) conducted by TNS healthcare (for-
merly Département Santé TNS Sofres). The method of the
fieldwork was described earlier [16]. The overall response
rate was 52.6% (UK 33%, Germany 29%, Italy 77%, Spain
57%, France 67%). Data from Spain were available since
2002/03. French data were collected via a postal question-
naire by GEIG (Groupe d'Etude et d'Information sur la
Grippe). 3991 people aged 15 years and over responded
to the questionnaire. In order to adjust the sample size
with that of the other countries, French data were
weighted according to standard criteria to represent 2000
individuals instead of 3991. The survey population was
representative of the adult population aged 14 years or
older in Germany, Italy and Spain, 15 years or older in
France and 16 years or older in the UK. In Spain, individ-
uals over 75 years of age we not included in the survey.
According to the Esomar World Research Codes and
Guidelines this type of study is considered market
research and does not require the approval of an ethics
committee, as this survey is a research in people, which
are deemed healthy and not in the medical system [9]. At
the beginning of each call, the agreement and explicit ver-
bal consent of the interviewees was obtained. There was
no study intervention and the anonymity of the partici-
pants was guaranteed. To obtain a representative sample
of the national non-institutionalized population aged 14
and over, interviews were carried out according to quotas
and a weighting was applied in terms of gender, age, pro-
fession, geographic region and town size. Quotas and
weighting factors were based on data from official
national sources [17].BMC Public Health 2008, 8:272 http://www.biomedcentral.com/1471-2458/8/272
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Four target groups based upon international recommen-
dations were determined as follows [18-22]:
1. Individuals aged 65 years or older
2. Individuals who suffer from a chronic illness
3. Individuals working in the medical field (health care
workers)
4. Composite target group (individuals aged 65 and over
or who suffer from a chronic illness or who are healthcare
workers)
Individuals belonging to none of the four above-defined
target groups were classified as members of the non-target
group (seasons 2003/04–2006/07).
According to official recommendations of the five coun-
tries' governments, the group of chronically ill is defined
as children, adolescences and adults suffering from
chronic diseases of respiratory organs, including asthma,
chronic heart disease, chronic renal disease, diabetes, con-
genital or acquired immune deficiencies) [2,6,8,9,23-25].
The survey questions have been published earlier [17].
The questionnaire covered vaccination uptake, reasons for
and against vaccination, as well as general opinions
towards influenza vaccination. After 2003/04, additional
information on chronic illnesses was collected. In order to
identify chronically ill persons, examples were provided
to the respondents. Questions regarding influenza pan-
demics and avian influenza were added from season
2005/06.
The annual datasets were pooled (for analysis across all
five countries) and sample weights were applied to correct
for small deviations from the age and gender quotas
requested. SPSS® version 14 for Windows was used for the
statistical evaluation. Bivariate association of categorical
variables were assessed with the Chi squared test and the
Chi squared test for trend was used for evaluating time
trends of these variables. For all statistical tests, two-sided
p = 0.05 was used as the level of statistical significance. If
available, exact p-values were displayed. Ninety-five per-
cent confidence intervals (CI) were reported as appropri-
ate. Covariates identified as potential predictors of
influenza vaccination in univariate analysis were consid-
ered as candidates for multivariable analysis. Logistic
regression was used to identify independent correlates of
the outcome of interest, i.e. vaccination coverage. Due to
the descriptive nature of this data, no correction for mul-
tiple testing was made.
Results
Demographic data
During season 2006/07, 186,285 telephone contacts were
built up and 6,000 mails sent out. The questionnaire was
completed by 12,036 individuals. The overall sample con-
sisted of 58,027 interviewed persons since 2001. Table 1
gives an overview of the sample for the year 2006/07 only.
The samples were similarly composed over the years and
were representative of the population aged 14 or older
[17]. Spain was appeared to have a smaller proportion of
persons older than 65 years, as the survey did not cover
persons over 75 years of age in this country.
Vaccination rates in the general population
Overall vaccination coverage rates across all surveyed
countries are shown in Figure 1. The decreased rate in sea-
son 2006/07, compared to season 2005/06, was statisti-
cally significant (p = 0.012). It was mainly due to coverage
changes in Germany and Spain. The rates seen in the other
countries were essentially constant. In contrast, across all
six seasons, a significant positive trend (p ≤ 0.0001) was
identified overall and in the UK, Germany, Italy and
Table 1: Overview of sample in season 2006/07
UK Germany Italy France Spain All
Total (N) 2037 2007 2001 2000 2000 10045
Mean age (years) 45 47.6 45.1 46.4 42 45.2
(95% CI) (44.1; 45.8) (46.8; 48.4) (44.3; 45.9) (45.6; 47.2) (41.3; 42.7) (44.9; 45.6)
Female 51.4% 51.9% 51.3% 51.9% 50.4% 51.4%
(95% CI) (49.4%; 54.4%) (49.9%; 53.9%) (49.3%; 53.3%) (49.9%; 53.9%) (48.4%; 53.4%) (50.4%; 52.4%)
Age ≥ 65 years 18.9% 24.0% 17.4% 20.0% 12.3% 18.5%
(95% CI) (17.9%; 20.9%) (22.0%; 26.0%) (16.4%; 19.4%) (18.0%; 22.0%) (11.3%; 14.3%) (18.7%; 19.1%)
Work in the medical field 6.4% 8.5% 4.2% 7.0% 4.9% 6.2%
(95% CI) (5.3%; 7.4%) (7.3%; 9.7%) (3.3%; 5.1%) (5.8%; 8.1%) (4.0%; 5.8%) (5.7%; 6.7%)
Chronic illness 14.5% 24.6% 13.9% 16.9% 13.2% 16.6%
(95% CI) (12.9%; 16.0%) (22.7%; 26.5%) (12.4%; 15.4%) (15.3%; 18.6%) (11.7%; 14.6%) (15.9%; 17.3%)
Combined target group1 33.2% 44.5% 29.4% 36.1% 25.7% 33.8%
(95% CI) (31.1%; 35.2%) (42.3%; 46.7%) (27.4%; 31.4%) (34.0%; 38.2%) (23.8%; 27.6%) (32.9%; 34.7%)
1 Includes people aged 65 years or over, suffering of chronic illness or working in medical fieldBMC Public Health 2008, 8:272 http://www.biomedcentral.com/1471-2458/8/272
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Spain. The differences in coverage between the five coun-
tries were statistically significant (p = 0.002).
Vaccination status in season 2006/07 is shown in Figure
2. Across all six seasons a statistically significant decrease
in the overall proportion of never vaccinated individuals
was evident (chi-squared test for trend, p ≤ 0.0001). How-
ever, the overall proportion of individuals vaccinated in
the past but not in season 2006/07 increased by 2.0%. The
overall proportion of first time immunizations was signif-
icantly lower by 4.0% in 2006/07 compared to 2005/06
(p ≤ 0.0001).
With regard to the coming winter of 2007/08, across all
countries, 36.6% of the interviewees intended to get vac-
cinated against the flu (-2.4% compared to the year
before). In all years and across all countries, vaccination
intentions were higher than the actual coverage rates
achieved. The ratio between actual and intended vaccina-
tion coverage (across countries) remained stable over the
years (range: 0.63 in 2001/02 and 0.7 in 2004/05). The
gaps were highest in Germany and lowest in France.
With respect to gender, no significant associations were
found at the country level in season 2006/07. In the UK,
a slightly stronger vaccination attendance among females
was detected (unadjusted OR 1.2, p = 0.062), whereas in
Spain men were more likely to get an immunisation
(unadjusted OR: 0.9, p = 0.123). Across all six seasons, a
significant gender difference was noted in the UK (p =
0.0001, men<female), in Italy (p = 0.004, men>female)
and in Spain (p = 0.005, men>female).
Vaccination rates and trends in target groups
Predictors of vaccination (age, working in the medical
field and suffering from chronic illness) were investigated
using multivariate logistic regression. The reference group
were individuals who belonged to the non-target group.
The effect of gender was statistically not relevant and was
debarred from the final multivariate analysis.
Seasonal Influenza Vaccine Coverage in the general population in 5 European countries by season (2001/02–2006/07) Figure 1
Seasonal Influenza Vaccine Coverage in the general population in 5 European countries by season (2001/02–
2006/07).
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Age
Figures 3 show that the highest coverage among the eld-
erly above age 65 was achieved in Spain (69.5%, 95% CI:
62.5%; 76.5%) (Fig 3e). Germany had the lowest coverage
rate (50.2%; 95% CI: 44.2%; 56.2%) even though the
only statistically significant time trend of increasing cover-
age rates (p = 0.011) was found here (Fig 3b). Vaccination
coverage in season 2006/07 by age group is shown in Fig-
ure 4.
Table 2 shows the multivariate-adjusted impact of belong-
ing to the elderly target group, on the probability of get-
ting vaccinated, which was similar in seasons 2006/07
and 2005/06. Since 2003/04, an overall upward trend
could be statistically confirmed (p = 0.005).
Chronic illness
A question concerning the vaccination status of chroni-
cally ill persons was added to the questionnaire in 2003/
04. In the presence of chronic illness (like heart or lung
disease, diabetes or others), vaccination rates were higher
than in the non-target group. In season 2006/07, they
ranged from 29.8% (95%CI 23.8%; 35.8%) in Germany
to 59.4% (95% CI 52.4%; 57.4%) in the UK. (see Figs 3).
Correspondingly, chronic illness was a strong predictor of
vaccination (Tab 2). Being old and chronically ill boosted
the adjusted ORs in all five countries even more. They
reached 20.1 (95% CI 16.6; 24.4) on average. In France,
the probability of getting vaccinated was nearly ten times
higher than in the group of chronically ill persons who
were not old.
Working in the medical field
In season 2006/07, as in the previous seasons, there were
substantial differences between the individual countries:
in Germany, the rate of vaccinated medical care workers
(22.6%, CI 14.6%; 29.6%) was nearly twice as high as in
Italy (12.2%, CI 4.2%; 20.2%) (Figs 3). Over time, health-
care workers showed a continuous decrease in immuniza-
Vaccination rates according to vaccination status (season 2006/07) Figure 2
Vaccination rates according to vaccination status (season 2006/07).
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tion uptake compared to the non target group. Only
France showed an increasing but not significant trend (p
= 0.217).
It is consistent with these findings that working as a health
care professional was not a strong driver of vaccination in
multivariate regression (Tab 2).
Combined target group and non-target group
In the composite target group (including individuals aged
65 and over or who suffered from a chronic illness or who
were healthcare workers) a vaccination rate below 50%
was only seen in Germany (40.9%, CI 37.9%; 43.9% in
2006/07). Spain (50.6%, CI: 45.6%; 54.6%), Italy
(51.0%, CI: 47.0%; 55.0%), France (51.4%, CI: 48.4%;
55.4%) and UK (57.9%, CI: 53.9%; 61.9%) showed a
higher coverage by far. Vaccination coverage in the non-
target group was essentially stable across seasons (Figs 3).
Drivers and barriers to vaccination
Table 3 shows reasons for getting and not getting vacci-
nated in season 2006/07. The principal driver of vaccina-
tion was receiving an advice from the family doctor
(average 51%, previous season 49%). Media attention on
avian flu led 6% of the overall population to get a flu
immunisation (previous season 7%). In France, the most
Trend curves of actual vaccination rates in high-risk target groups (vs. non-target group) and in the non-target group in all five  countries (seasons 2003/04–2006/07) Figure 3
Trend curves of actual vaccination rates in high-risk target groups (vs. non-target group) and in the non-target 
group in all five countries (seasons 2003/04–2006/07). 3a. UK. 3b. Germany. 3c. Italy. 3d. France. 3e. Spain.
(p values for trend across seasons)BMC Public Health 2008, 8:272 http://www.biomedcentral.com/1471-2458/8/272
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frequently stated reason was, like in the previous year, that
the vaccine is paid by the social security system. Rankings
of these driving forces did not change to a large extent.
With respect to barriers to vaccination, some differences
were observed between the five countries covered (Tab 3).
The answers given were in accordance with the respective
data for 2005/06.
Knowledge about influenza and vaccination was very sim-
ilar as in season 2005/06. Across all five countries, fre-
quent statements were "you can catch the flu even if you
are vaccinated" (65.0%) or "the infection is less sever if
you are previously vaccinated" (54.9%). It is noteworthy
that 22.6% were in agreement with the opinion that one
will not catch the flu if one is vaccinated and that the vac-
cine will protect oneself in case of avian influenza or an
influenza pandemic (18.6%). Do not know answers were
below 32% for all items.
Answers regarding encouragements to vaccination are
shown in Table 4. For France, only a limited amount of
data was available concerning this topic.
Discussion
Every year, the burden of seasonal flu is considerable. Vac-
cination coverage among non- and high-risk target groups
is still not sufficient although effectiveness of flu vaccina-
tion is clearly demonstrated. To improve vaccination
uptake, it is indispensable to gain insight into the vaccina-
tion uptake among different risk groups and to deal with
the drivers and barriers to vaccination, in the population.
During six consecutive seasons (2001–2007), national
surveys in the UK, Germany, Italy, France and Spain have
been conducted to examine influenza vaccination cover-
age rates. Monitoring of the coverage in different target
groups were carried out by telephone interviews using a
CATI system (except in France), which is known as a suit-
Vaccinated population by age group (season 2006/07) Figure 4
Vaccinated population by age group (season 2006/07).
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able way of establishing influenza vaccination coverage in
different groups of the population [26,27]. Mobile only
users were not integrated in the survey as they are usually
hard to reach and the costs of the interviews would be
boosted. In France, self-administered questionnaires were
sent out by letter. This methodology was already used suc-
cessfully in the past [28,29].
During the season 2006/07, the vaccination coverage rate
in the total sample decreased slightly to 24.5% compared
to the previous season. However, a general trend towards
slightly increasing coverage rates in the 5 European coun-
tries covered may still be intact.
Vaccination coverage in the elderly, in chronically ill per-
sons and in persons working in the medical field varied
strongly across countries and was rather low in some
cases. A high proportion of vaccinated non-target group
members in Germany (defined as persons <65 years, not
chronically ill, not working as health care workers) can be
attributed to the fact that here, other than in the remain-
ing countries, vaccination is recommended for people
aged 60 and over [30].
In the UK and Germany, 2006/07 compliance rates with
influenza vaccination recommendations in those aged 65
years or older were below the level of 2005/06. In con-
trast, Italy, Spain and also France indicated higher vacci-
nation rates in their elderly populations. Kroneman et al.
found similar coverage rates in the elderly populations of
Spain (67%) and Germany (53%) [31]. All five countries
met the WHO objective of realising a 50% coverage in the
elderly population in 2006, although Germany showed a
borderline situation in this respect.
Another predisposing factor favourably affecting vaccina-
tion rates are chronic illnesses. A decrease in coverage,
with respect to this target group, was seen in Spain and
Germany. High coverage in UK may have been due to the
fact that general practitioners were encouraged to proac-
tively recommend the vaccine to their at risk patients [22].
The observation of a larger proportion of chronically ill
persons in Germany compared to the rest of the observed
countries remained unclear, since the wording of the
question was the same in all five countries. Interestingly,
this result is in line with an earlier cross-sectional study,
which found a 20 percent proportion of Germans who
stated to belong to this group [31].
Table 2: Adjusted odds ratios of vaccination coverage in target groups vs. the non-target group (adjustment for age ≥ 65 years, chronic 
illness, working in the medical field), in season 2006/07
UK Germany Italy France Spain All
(n = 2026°) (n = 1996°) (n = 2001) (n = 3798°) (n = 1994°) (n = 11,815°)
Age* 20 5.2 9.9 17.4 16.9 11.9
(95% CI) (14.6; 27.3) (3.9; 7.0) (7.3; 13.4) (12.6; 24.0) (11.7; 24.3) (10.3; 13.6)
p-value <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001
N 258 234 260 759 168 1679
Chronic illness* 15.5 2.2 3.8 5.3 4.4 4.8
(95% CI) (10.8; 22.2) (1.6; 3.0) (2.7; 5.5) (3.7; 7.5) (3.1; 6.3) (4.1; 5.5)
p-value <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001
N 186 231 159 321 172 1069
Chronic illness and age* 51.9 7.2 22.2 49.7 21 20.1
(95% CI) (30.1; 89.6) (5.2; 10.0) (13.9; 35.5) (29.4; 84.1) (12.4; 35.8) (16.6; 24.4)
p-value <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001 <= 0.0001
N 119 167 125 354 78 843
Work in medical field * 2 1.5 0.9 2.9 1.9 1.8
(95% CI) (1.2; 3.5) (1.0; 2.4) (0.4; 1.8) (1.8; 4.7) (1.1; 3.3) (1.4; 2.3)
p-value 0.012 0.065 0.772 <= 0.0001 0.026 <= 0.0001
N 118 122 73 222 84 619
Work in medical field and chronic ill or age* 3.9 1.1 5.4 7.4 6.2 3.2
(95% CI) (1.4; 10.9) (0.5; 2.5) (1.6; 18.3) (2.6; 21.1) (2.2; 17.1) (2.1; 5.0)
p-value 0.01 0.749 0.007 <= 0.0001 <= 0.0001 <= 0.0001
N 1 73 91 13 01 61 1 3
°N < total sample size for this season due to missing covariate values.
*Reference category: non-target group (persons who do not belong to any target group)BMC Public Health 2008, 8:272 http://www.biomedcentral.com/1471-2458/8/272
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The fact of suboptimal influenza immunization rates in
health care professionals is well known [32]. Our study
indicated a coverage which was lower than in all previous
seasons covered by this survey. A low activity level of the
influenza virus and a related late start of the influenza sea-
sons may have reduced the attention of healthcare profes-
sionals in the last two years [33,34]. On the other hand, a
survey using anonymous questionnaires carried out at the
University Hospital Frankfurt, Germany, indicated a dis-
tinctly higher vaccination rate of 35.8%, while still dis-
closing a low acceptance of influenza vaccination among
the healthcare professionals [35]. In single centres with a
defined strategy, it may be possible to achieve noticeably
higher vaccination rates than in all health care workers on
average (including those who are not institution-based).
This may provide an explanation for this apparent dis-
crepancy. Interestingly, healthcare workers do not only
regard the vaccination as a protection for their patients,
but in the first instance as a protection for themselves
[36].
Table 3: Ranking of reasons for and against vaccination in season 2006/07 (First six ranks)
Motivations for getting vaccinated UK Germany Italy France Spain All
(n = 509) (n = 549) (n = 488) (n = 485) (n = 435) (n = 2465)
Rank (%) Rank (%) Rank (%) Rank (%) Rank (%) Rank (%)
My family doctor/nurse advised me to do it 1 (60) 2 (71) 1 (43) 3 (34) 1 (44) 1 (51)
Because the flu is a serious illness and I did not want to get it 2 (50) 1 (90) 2 (24) 3 (34) 2 (37) 2 (48)
Because of my age 3 (42) 5 (39) 5 (15) 2 (37) 3 (30) 3 (33)
Because I am not in very good health 4 (32) 6 (31) 3 (23) 6 (15) 4 (21) 6 (25)
So I do not pass the flu bug to my family/friends 5 (32) 3 (69) 4 (17) 5 (17) 5 (19) 5 (32)
Because the social security system pays for it 6 (29) 4 (46) 6 (6) 1 (47) 6 (19) 4 (30)
Reasons for not getting vaccinated 
(among those never vaccinated)
UK Germany Italy France Spain All
(n = 1183) (n = 900) (n = 1338) (n = 1291) (n = 1289) (n = 6001)
Rank (%) Rank (%) Rank (%) Rank (%) Rank (%) Rank (%)
I do not think I am very likely to catch the flu 3 (33) 1 (48) 2 (22) 3 (18) 1 (63) 1 (36)
I have never considered it before 2 (35) 6 (31) 1 (38) 2 (21) 2 (43) 2 (34)
My family doctor did not recommend it to me 1 (38) 4 (39) 4 (14) 4 (17) 3 (25) 3 (26)
I am too young to be vaccinated 4 (32) 5 (12) 1 (35) 4 (18) 4 (22)
It is not a serious enough illness 3 (40) 3 (17) 6 (11) 5 (18)
I don't like injections/needles 6 (11) 5 (13) 6 (14)
My doctor at work has never recommended it to me 5 (21)
My pharmacist has never recommended it to me 6 (21) 5 (33)
I thought about it but I didn't end up getting vaccinated 2 (47)
I don't think the vaccine is effective enough 5 (12)
It is too expensive/not reimbursed 5 (17)
Table 4: Encouragements for vaccination in season 2006/07
UK Germany Italy France Spain All
(n = 2037) (n = 2007) (n = 2001) (n = 2000) (n = 2000) (n = 10045)
Rank (%) Rank (%) Rank (%) Rank (%) Rank (%) Rank (%)
If my family doctor/nurse recommended it to me 1 (72) 1 (68) 1 (55) 1 (37) 1 (73) 1 (61)
If I had more information on the vaccine regarding efficacy and/or 
tolerance
2 (46) 2 (55) 2 (30) - 2 (37) 2 (34)
If I knew more about the disease 4 (37) 3 (52) 3 (18) - 3 (29) 3 (27)
If I could be vaccinated at work 6 (30) 5 (42) 8 (9) 3 (12) 3 (29) 4 (24)
If there were other ways of administering the vaccine 
(orally, injection without needle)
5 (34) 6 (40) 5 (11) 4 (10) 5 (24) 5 (24)
If it where cheaper/reimbursed/free 7 (25) 4 (44) 6 (10) 2 (24) 8 (7) 6 (22)
If my pharmacist recommended it to me 3 (39) 7 (33) 7 (9) 6 (3) 6 (17) 7 (20)
If there was more information on it generally - - - 5 (9) - -
I would not change my mind 8 (9) 8 (10) 4 (17) - 7 (11) 8 (10)
- No data availableBMC Public Health 2008, 8:272 http://www.biomedcentral.com/1471-2458/8/272
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Our study showed that the most important encouraging
factors for reaching higher coverage rates were a proactive
behaviour of healthcare workers as well as the implemen-
tation of effective public communication and education
campaigns on influenza and influenza vaccine. Percep-
tion of the flu as a serious illness and recommendation by
a family doctor were the principal reasons for getting vac-
cinated. In the literature, the advice of healthcare profes-
sionals is constantly reported to have a positive influence
on coverage rates [15,37,38]. The attention on avian flu
was not a strong driving force in season 2006/07. Fear of
catching the bird flu may have waned due to reduced
media coverage of influenza and avian influenza [39].
Hence, delayed vaccination campaigns due to late availa-
bility of the vaccine and decreasing public attention on flu
and avian flu as a result of reduced media coverage and
weakening political attention may have contributed to the
decrease of immunisation uptake seen in some countries
in season 2006/07.
Considering the entire study population, the ratio of
actual and intended vaccination rate was 0.67 across
Europe. Only France seemed to have a more realistic view,
if they will be vaccinated the coming winter or not
(actual/intended vaccination rate = 0.84). However, the
discrepancy between vaccination intentions and actually
receiving vaccination shows the potential for an increase
in vaccination rates in the future. Efforts should be made
at national and international levels to enhance the cover-
age rates and to achieve the WHO objectives of a 75% cov-
erage in 2010 in the elderly population.
Conclusion
In Europe, influenza vaccination coverage needs to be
improved. By encouraging health care workers to proac-
tively propose the influenza vaccination to the at-risk
groups and to get their own flu shot, by wide and effective
public communication and education campaigns on
influenza as a disease and the mode of action of the vac-
cine, and by adequate funding, vaccination coverage rates
can be increased. In five European countries covered here,
coverage in the elderly exceeds the goal of the WHO and
the European Parliament (The European Parliament reso-
lution [P6_TA(2005)0406] on the strategy against an
influenza pandemic, 26 October 2005) to vaccinate 50%
of the aged population by 2006. However, efforts have to
be made at the national and international levels to
enhance the coverage rates in all target groups to achieve
the WHO objective of a 75% coverage in the elderly in
2010.
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